Has FDA Become 'Big Pharma' Alumni Club?
June 16, 2013
Television Broadcast
On this television show, Dechert LLP's Hope Freiwald discusses the growing number of pharma representatives in the U.S. Food and Drug Administration and examines a number of related subjects including:
- the questionable approval of certain drugs
- the high turnover of deputy commissioners
- controversies surrounding advisory committees
- allegations of unwarranted pharmaceutical company influence under the George W. Bush and Obama administrations
